Skip to main content
. 2022 Mar 8;9:838761. doi: 10.3389/fcvm.2022.838761

Table 2.

Logistic analysis for predictors of NOAF in STEMI patients following PCI.

Variables OR 95% CI P
Univariate analysis
Age 1.056 1.026–1.087 <0.001
Gender 0.607 0.300–1.227 0.164
Hypertension 1.765 0.925–3.371 0.085
Diabetes mellitus 4.309 2.255–8.236 <0.001
Killip class ≥ II 3.022 1.598–5.717 0.001
Smoking 0.824 0.439–1.547 0.546
Alcohol intake 1.149 0.612–2.157 0.666
Body mass index 1.221 1.015–1.470 0.034
Hemoglobin 0.984 0.965–1.003 0.094
White blood cell 1.176 1.088–1.270 <0.001
Neutrophil 1.127 1.049–1.211 0.001
Platelet 0.995 0.988–1.001 0.083
Glucose 1.177 1.093–1.268 <0.001
Total cholesterol 0.747 0.538–1.037 0.081
Triglyceride 1.478 1.205–1.813 <0.001
HDL-c 2.979 0.953–9.315 0.060
LDL-c 0.536 0.334–0.859 0.009
TyG index 3.551 2.314–5.449 <0.001
eGFR 0.988 0.979–0.997 0.009
Peak CK 1.000 1.000–1.000 0.964
Uric acid 1.002 0.999–1.004 0.122
Albumin 0.941 0.867–1.002 0.149
TIMI flow grade <3 pre-PCI 0.588 0.242–1.430 0.242
Culprit vessel LADa 0.710 0.160–3.157 0.653
Culprit vessel LCXa 1.450 0.760–2.769 0.260
Stent length 1.023 1.004–1.043 0.018
SYNTAX score 1.046 1.000–1.094 0.052
Left atrium diameter 1.132 1.061–1.209 <0.001
LVEF 0.943 0.904–0.984 0.007
ACEI/ARB 1.084 0.487–2.411 0.844
Beta blocker 0.894 0.452–1.767 0.746
MRA 1.095 0.582–2.061 0.778
Statin 0.321 0.066–1.561 0.159
Multivariate analysis b
Age 1.058 1.013–1.105 0.011
TyG index 8.884 1.570–50.265 0.014
eGFR 0.987 0.976–0.998 0.022

NOAF, new-onset atrial fibrillation; STEMI, ST-segment elevation myocardial infarction; PCI, percutaneous coronary intervention; OR, odds ratio; CI, confidence interval; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; TyG index, Triglyceride-glucose index; eGFR, estimated glomerular filtration rate; CK, creatine kinase; TIMI, Thrombolysis In Myocardial Infarction; SYNTAX, SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery; LVEF, left ventricular ejection fraction, ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; MRA, mineralocorticoid receptor antagonist.

a

Compared with culprit vessel RCA.

b

Age, Hypertension, Diabetes mellitus, Body mass index, Hemoglobin, White blood cell, Neutrophil, Platelet, Glucose, Triglyceride, Total cholesterol, HDL-c, LDL-c, eGFR, TyG index, Left atrium diameter, LVEF, SS, Stent length and Killip class ≥ II had been included in the multivariate logistic regression analysis.